G 13 7
Pill imprint G 13 7 has been identified as Oxcarbazepine 150 mg.
Oxcarbazepine is used in the treatment of seizures; bipolar disorder; anxiety; trigeminal neuralgia and belongs to the drug class dibenzazepine anticonvulsants. Risk cannot be ruled out during pregnancy.
Oxcarbazepine 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Oxcarbazepine Images
- Imprint:
-
G
13 7 - Strength:
- 150 mg
- Color:
- Yellow
- Size:
- 11.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
crospovidone
ferric oxide yellow
hypromellose
magnesium stearate
meglumine
microcrystalline cellulose
polyethylene glycol
titanium dioxide
- Drug Class:
- Dibenzazepine anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Glenmark Generics Inc.
- National Drug Code (NDC):
- 68462-0137
| NDC Code | Manufacturer / Repackager |
|---|---|
| 33261-0684 | Aidarex Pharmacuticals LLC (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Oxcarbazepine resources
- Oxcarbazepine (Wolters Kluwer)
- Oxcarbazepine Suspension (Wolters Kluwer)
- oxcarbazepine (Cerner Multum)
- oxcarbazepine (Micromedex) - Includes Dosage Information
- Oxcarbazepine (AHFS DI)
- Oxcarbazepine (FDA)
- Oxcarbazepine Suspension (FDA)
- Oxcarbazepine (Wolters Kluwer)
Search Again
